Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (GB:0A23)
LSE:0A23
Phreesia (0A23) Share Price & Analysis
0 Followers
0A23 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.27 - $30.46
Previous Close$24.55
Volume19.00
Average Volume (3M)348.00
Market Cap
$1.40B
Enterprise Value$1.34B
Total Cash (Recent Filing)$79.53M
Total Debt (Recent Filing)$17.50M
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Sep 10, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding57,397,904
10 Day Avg. Volume182
30 Day Avg. Volume348
Standard Deviation0.19
R-Squared0.18
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)11.88
Price to Sales (P/S)39.47
Price to Cash Flow (P/CF)-94.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.59
Enterprise Value/Gross Profit5.77
Enterprise Value/Ebitda-23.61
Forecast
1Y Price Target
$28.89Price Target Upside17.66% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Phreesia News
PremiumCompany Announcements
Phreesia Appoints Yvonne Hui as New Principal Accounting Officer
PremiumCompany Announcements
Phreesia’s Global Hurdle: Navigating Legal Complexities Abroad
PremiumThe Fly
Phreesia falls -14.5%Bulls Say, Bears Say
Bulls Say
Market PositionPhreesia has a strong market position and is a leading brand, facilitating more than 150 million visits, or over 10% of patient visits in the U.S.
Network Solutions GrowthThe important focal point for investors should be on high margin Network Solutions pharma brand marketing offering, which grew 26.3%.
ProfitabilityEBITDA of $4M vs. losses of $14M YoY, representing first quarter of profitability in 3 years.
Bears Say
Cyber IncidentPotential effects of the ongoing cyber incident affecting Ascension Healthcare, a Phreesia customer, which has had to divert patients from certain hospitals to other providers.
FY25 OutlookThe updated FY25 guidance includes an $8mm topline decrease due to an unexpected accelerated clearinghouse customer wind-down.
Revenue GuidanceThe accelerated wind-down of a relationship with a clearinghouse client drove revenue guidance down by $8.0 million.
---
Options Prices
Currently, No data available
---
Ownership Overview
20.43% Insiders
45.54% Mutual Funds
13.65% Other Institutional Investors
20.38% Public Companies and
Individual Investors
0A23 FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest share price was $12.27 and its highest was $30.46 in the past 12 months.
What is Phreesia’s market cap?
Currently, no data Available
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Sep 10, 2024 which is in 45 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on May 30, 2024. The company reported -$0.35 earnings per share for the quarter, beating the consensus estimate of -$0.468 by $0.118.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -$0.36.
How many shares outstanding does Phreesia have?
Phreesia has 57,397,903 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.35 in its last earnings report, beating expectations of -$0.468. Following the earnings report the stock price went down -17.071%.
Which hedge fund is a major shareholder of Phreesia?
Among the largest hedge funds holding Phreesia’s share is Bridgewater Associates, LP. It holds Phreesia’s shares valued at 2M.
---
Phreesia Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$28.89 (17.66% Upside)
$28.89 (17.66% Upside)
Blogger Sentiment
Bullish
GB:0A23 Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $209.6K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.43%
12-Months-Change
Fundamentals
Return on Equity
-46.12%
Trailing 12-Months
Asset Growth
5.15%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
0A23 Company Deck
---
0A23 Earnings Call
Q1 2024
0:00 / 0:00
---
0A23 Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
0A23 Stock 12 Month Forecast
Average Price Target
$28.89
▲(17.66% Upside)
Technical Analysis
Best Analysts Covering 0A23
1 Year
1 Year Success Rate
5/10 ratings generated profit
1 Year Average Return
-9.32%
reiterated a buy rating 2 months ago
Copying Anne Samuel's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -9.32% per trade.
---